Procurement Summary
Country: Macedonia
Summary: Tablet and Ampoule Therapy (Medicines that are not on the Positive List)
Deadline: 14 May 2026
Posting Date: 15 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139539129
Document Ref. No.: 06369/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
33673000 - Medicinal products for obstructive airway diseases
33670000 - Medicinal products for the respiratory system
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33693000 - Other therapeutic products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
PART 1 B01AC06 Acetylsalicylic acid, PART 2 C01EB10 Adenosine, PART 3 N04BB01 Amantadine, PART 4 N04BB01 Amantadine, PART 5 A12AA03 B05BB01 Calcium gluconate, PART 6 N06BX Cerebrolysin concentrat, PART 7 B02BD01 Coagulation factor IX, II, VII and X in combination, PART 8 M03CA01 Dantrolene, PART 9 N05CM18 Dexmedetomidine, PART 10 N05CM18 Dexmedetomidine, PART 11 C01CA26 Ephedrine, PART 12 C07AB09 Esmolol, PART 13 A02BA03 Famotidine, PART 14 M01AE01 Ibuprofen, PART 15 A07FA51 Lactic acid producing organisms, combinations, PART 16 N01BB02 Lidocaine, PART 17 N01BB02 Lidocaine, PART 18 J01X08 Linezolid, PART 19 B05XA05 Magnesium sulfate, PART 20 N02BB02 Metamizole sodium, PART 21 C08CA06 Nimodipine, PART 22 C01CA06 Phenylephrine, PART 23 C01CA06 Phenylephrine, PART 24 N05AA03 Promazine, PART 24 25 V03AB35 Sugammadex, Д 26 N05AL01 Sulpiride, Д 27 B02AA02 Tranexamic acid, Д 28 H01BA01 Vasopressin (argipressin), Д 29 R03BB01 Ipratropium bromide, Д 30 B02BB01 human fibrinogen, ДЕЛ 31 J01DI02 ceftaroline fosamil, ДЕЛ 32 J01DD52 ceftazidime avibactam, ДЕЛ 33 A01AB12 Hexetidine, DEL 34 N02BE51 paracetamol, ibuprofen D, EL 35 J01AA12 Tygex, DEL 36 S01BC08 Salicylic acid,
CPV Descriptions: Medical products for the treatment of diseases causing airway obstruction, Medical products for the respiratory system, General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulating agents, Medical products for dermatology and the musculoskeletal system, Other therapeutic products
Documents
Tender Notice
Document_1.xlsx
Document_2.docx
Document_3.doc
Document_4.pdf